The Compound Report is an educational resource. Nothing on this site constitutes medical advice or encourages personal use of any compound. Always consult a qualified healthcare provider.
Sirolimus
mTORC1 inhibitor with the strongest longevity evidence of any pharmacologic in mammals. Pulsatile dosing protocols dominant.